Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder

Status unconfirmed · Phase 2 · Has a placebo group

Conditions studied: Female Sexual Arousal Disorder

In brief

This study is looking to minimize side effects, while maintaining and potentially improving the therapeutic benefit to patients suffering from Female Sexual Arousal Disorder by providing a topical preparation of Sildenafil locally to the vulvar-vaginal tissue.

Key facts

Study ID
NCT04948151
Run by
Strategic Science & Technologies, LLC
People needed
440
Starts
2021-06-28
Expected to finish
2021-12-15
Last updated by the study team
2021-07-01

Who can join

Age: 21 and older. Sex: female. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.